
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES114
A Cochrane review237 found a significant reduction in the risk of ESRD with A2RB compared
to placebo/no treatment (three studies, N=3,251): RR 0.78, 95% CI 0.67 to 0.91. Level 1++

[@2005]

